News

Filter

Official: Merck & Co to acquire Cubist for $8.4 billion

Official: Merck & Co to acquire Cubist for $8.4 billion

08-12-2014

Confirming weekend speculation and rumors, US pharma giant Merck & Co this morning said it has entered…

Antibiotics and Infectious diseasesBiotechnologyCubicinCubist PharmaceuticalsMerck & CoMergers & AcquisitionsZerbaxa

Sources say Merck to buy Cubist in $7 billion deal

Sources say Merck to buy Cubist in $7 billion deal

08-12-2014

Sources close to the matter say pharma giant Merck & Co has entered negotiations with Cubist Pharmaceuticals…

CubicinCubist PharmaceuticalsMerck & CoMergers & AcquisitionsPharmaceuticalUSA

Majority of US surveyed MCOs will consider reimbursing novel OPAT agents; report

17-08-2011

According to surveyed physicians in the USA, the use of out-patient parenteral antibiotic therapy (OPAT)…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsForest LaboratoriesIvanzMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalTeflaroTheravanceVibativ

COMPANY SPOTLIGHT

Menarini

Back to top